{"id":"https://openalex.org/W2313882001","doi":"https://doi.org/10.1097/cad.0000000000000314","title":"Phase II trial of irinotecan and metronomic temozolomide in patients with recurrent glioblastoma","display_name":"Phase II trial of irinotecan and metronomic temozolomide in patients with recurrent glioblastoma","publication_year":2015,"publication_date":"2015-11-17","ids":{"openalex":"https://openalex.org/W2313882001","doi":"https://doi.org/10.1097/cad.0000000000000314","mag":"2313882001","pmid":"https://pubmed.ncbi.nlm.nih.gov/26574999"},"language":"en","primary_location":{"id":"doi:10.1097/cad.0000000000000314","doi":"https://doi.org/10.1097/cad.0000000000000314","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cad.0000000000000314","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009835210","display_name":"Gaspar Reyn\u00e9s","orcid":"https://orcid.org/0000-0001-8636-6094","observed_orcids":["https://orcid.org/0000-0001-8636-6094"]},"institutions":[{"id":"https://openalex.org/I2960094004","display_name":"Hospital General Universitario Gregorio Mara\u00f1\u00f3n","ror":"https://ror.org/0111es613","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2960094004","https://openalex.org/I4210139293"]},{"id":"https://openalex.org/I2961216182","display_name":"Hospital Cl\u00ednico San Carlos","ror":"https://ror.org/04d0ybj29","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2961216182","https://openalex.org/I4210139293"]},{"id":"https://openalex.org/I3019010403","display_name":"Hospital Universitari i Polit\u00e8cnic La Fe","ror":"https://ror.org/01ar2v535","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I3019010403","https://openalex.org/I4210166036"]},{"id":"https://openalex.org/I4210094406","display_name":"Hospital Cl\u00ednico Universitario de Valencia","ror":"https://ror.org/00hpnj894","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210094406"]},{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]},{"id":"https://openalex.org/I4210161852","display_name":"Hospital Universitario Ram\u00f3n y Cajal","ror":"https://ror.org/050eq1942","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210139293","https://openalex.org/I4210161852"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Gaspar Reyn\u00e9s","raw_affiliation_strings":["aDepartment of Medical Oncology bResearch Center, Hospital Universitari i Polit\u00e8cnic La Fe cDepartment of Hematology and Medical Oncology, Hospital Cl\u00ednico Universitario de Valencia, Valencia dDepartment of Medical Oncology, Institut Catal\u00e0 d'Oncologia, Badalona eDepartment of Medical Oncology, Hospital Cl\u00ednico Universitario San Carlos fDepartment of Medical Oncology, Hospital Universitario Ram\u00f3n y Cajal gDepartment of Medical Oncology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid hDepartment of Medical Oncology, Hospital Regional Universitario Carlos Haya, M\u00e1laga iDepartment of Medical Oncology, Hospital Sant Pau jDepartment of Medical Oncology, Institut Catal\u00e0 d'Oncologia-IDIBELL, l'Hospitalet de Llobregat, Barcelona, Spain","Department of Medical Oncology","e-mail: [email\u00a0protected]","fax: +34 961246243","to Gaspar Reyn\u00e9s, MD, Department of Medical Oncology, Hospital Universitari i Polit\u00e8cnic La Fe, Avda. Fernando Abril Martorell no. 106, 46026 Valencia, Spain Tel: +34 961 244 000"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aDepartment of Medical Oncology bResearch Center, Hospital Universitari i Polit\u00e8cnic La Fe cDepartment of Hematology and Medical Oncology, Hospital Cl\u00ednico Universitario de Valencia, Valencia dDepartment of Medical Oncology, Institut Catal\u00e0 d'Oncologia, Badalona eDepartment of Medical Oncology, Hospital Cl\u00ednico Universitario San Carlos fDepartment of Medical Oncology, Hospital Universitario Ram\u00f3n y Cajal gDepartment of Medical Oncology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid hDepartment of Medical Oncology, Hospital Regional Universitario Carlos Haya, M\u00e1laga iDepartment of Medical Oncology, Hospital Sant Pau jDepartment of Medical Oncology, Institut Catal\u00e0 d'Oncologia-IDIBELL, l'Hospitalet de Llobregat, Barcelona, Spain","institution_ids":["https://openalex.org/I2960094004","https://openalex.org/I2961216182","https://openalex.org/I3019010403","https://openalex.org/I4210094406","https://openalex.org/I4210107147","https://openalex.org/I4210161852"]},{"raw_affiliation_string":"Department of Medical Oncology","institution_ids":[]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +34 961246243","institution_ids":[]},{"raw_affiliation_string":"to Gaspar Reyn\u00e9s, MD, Department of Medical Oncology, Hospital Universitari i Polit\u00e8cnic La Fe, Avda. Fernando Abril Martorell no. 106, 46026 Valencia, Spain Tel: +34 961 244 000","institution_ids":["https://openalex.org/I3019010403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110337704","display_name":"Vicenta Mart\u00ednez\u2010Sales","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019010403","display_name":"Hospital Universitari i Polit\u00e8cnic La Fe","ror":"https://ror.org/01ar2v535","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I3019010403","https://openalex.org/I4210166036"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Vicenta Mart\u00ednez-Sales","raw_affiliation_strings":["Research Center, Hospital Universitari i Polit\u00e8cnic La Fe"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Center, Hospital Universitari i Polit\u00e8cnic La Fe","institution_ids":["https://openalex.org/I3019010403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111672968","display_name":"Virtudes Vila","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019010403","display_name":"Hospital Universitari i Polit\u00e8cnic La Fe","ror":"https://ror.org/01ar2v535","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I3019010403","https://openalex.org/I4210166036"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Virtudes Vila","raw_affiliation_strings":["Research Center, Hospital Universitari i Polit\u00e8cnic La Fe"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Center, Hospital Universitari i Polit\u00e8cnic La Fe","institution_ids":["https://openalex.org/I3019010403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057499890","display_name":"Carmen Bala\u00f1\u00e1","orcid":"https://orcid.org/0000-0003-0771-0390","observed_orcids":["https://orcid.org/0000-0003-0771-0390"]},"institutions":[{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Carmen Bala\u00f1\u00e1","raw_affiliation_strings":["Department of Medical Oncology, Institut Catal\u00e0 d\u2019Oncologia, Badalona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Institut Catal\u00e0 d\u2019Oncologia, Badalona","institution_ids":["https://openalex.org/I4210107147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014016108","display_name":"Pedro P\u00e9rez\u2010Segura","orcid":"https://orcid.org/0000-0001-5049-7199","observed_orcids":["https://orcid.org/0000-0001-5049-7199"]},"institutions":[{"id":"https://openalex.org/I2961216182","display_name":"Hospital Cl\u00ednico San Carlos","ror":"https://ror.org/04d0ybj29","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2961216182","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Pedro P\u00e9rez-Segura","raw_affiliation_strings":["Department of Medical Oncology, Hospital Cl\u00ednico Universitario San Carlos"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hospital Cl\u00ednico Universitario San Carlos","institution_ids":["https://openalex.org/I2961216182"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101734070","display_name":"Mar\u00eda \u00c1ngeles Vaz Salgado","orcid":"https://orcid.org/0000-0002-5913-9002","observed_orcids":["https://orcid.org/0000-0002-5913-9002"]},"institutions":[{"id":"https://openalex.org/I4210161852","display_name":"Hospital Universitario Ram\u00f3n y Cajal","ror":"https://ror.org/050eq1942","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210139293","https://openalex.org/I4210161852"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Mar\u00eda A. Vaz","raw_affiliation_strings":["Department of Medical Oncology, Hospital Universitario Ram\u00f3n y Cajal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hospital Universitario Ram\u00f3n y Cajal","institution_ids":["https://openalex.org/I4210161852"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054498659","display_name":"Manuel Benavides","orcid":"https://orcid.org/0000-0002-9817-1291","observed_orcids":["https://orcid.org/0000-0002-9817-1291"]},"institutions":[{"id":"https://openalex.org/I4210108548","display_name":"Hospital Regional Universitario de M\u00e1laga","ror":"https://ror.org/01mqsmm97","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210108548"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Manuel Benavides","raw_affiliation_strings":["Department of Medical Oncology, Hospital Regional Universitario Carlos Haya, M\u00e1laga"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hospital Regional Universitario Carlos Haya, M\u00e1laga","institution_ids":["https://openalex.org/I4210108548"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082835290","display_name":"Oscar S. Gallego","orcid":"https://orcid.org/0000-0001-5665-0967","observed_orcids":["https://orcid.org/0000-0001-5665-0967"]},"institutions":[{"id":"https://openalex.org/I2801795740","display_name":"Hospital de Sant Pau","ror":"https://ror.org/059n1d175","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2801795740"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Oscar Gallego","raw_affiliation_strings":["Department of Medical Oncology, Hospital Sant Pau"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hospital Sant Pau","institution_ids":["https://openalex.org/I2801795740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049517066","display_name":"Isabel Palomero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2960094004","display_name":"Hospital General Universitario Gregorio Mara\u00f1\u00f3n","ror":"https://ror.org/0111es613","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2960094004","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Isabel Palomero","raw_affiliation_strings":["Department of Medical Oncology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid","institution_ids":["https://openalex.org/I2960094004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032379353","display_name":"Miguel Gil\u2010Gil","orcid":"https://orcid.org/0000-0003-1380-2718","observed_orcids":["https://orcid.org/0000-0003-1380-2718"]},"institutions":[{"id":"https://openalex.org/I4210087039","display_name":"Institut d'Investigaci\u00f3 Biom\u00e9dica de Bellvitge","ror":"https://ror.org/0008xqs48","country_code":"ES","type":"facility","lineage":["https://openalex.org/I157913058","https://openalex.org/I2802050225","https://openalex.org/I4210087039","https://openalex.org/I4210096656","https://openalex.org/I4210106543","https://openalex.org/I4210107147","https://openalex.org/I4210153292","https://openalex.org/I4387153040","https://openalex.org/I71999127"]},{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Miguel Gil-Gil","raw_affiliation_strings":["Department of Medical Oncology, Institut Catal\u00e0 d\u2019Oncologia-IDIBELL, l\u2019Hospitalet de Llobregat, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Institut Catal\u00e0 d\u2019Oncologia-IDIBELL, l\u2019Hospitalet de Llobregat, Barcelona, Spain","institution_ids":["https://openalex.org/I4210087039","https://openalex.org/I4210107147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050649627","display_name":"Tania Fleitas","orcid":"https://orcid.org/0000-0002-2789-9082","observed_orcids":["https://orcid.org/0000-0002-2789-9082"]},"institutions":[{"id":"https://openalex.org/I4210094406","display_name":"Hospital Cl\u00ednico Universitario de Valencia","ror":"https://ror.org/00hpnj894","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210094406"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Tania Fleitas","raw_affiliation_strings":["Department of Hematology and Medical Oncology, Hospital Cl\u00ednico Universitario de Valencia, Valencia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Medical Oncology, Hospital Cl\u00ednico Universitario de Valencia, Valencia","institution_ids":["https://openalex.org/I4210094406"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011161678","display_name":"Encarnaci\u00f3n Reche","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Encarnaci\u00f3n Reche","raw_affiliation_strings":["Department of Medical Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5009835210"],"corresponding_institution_ids":["https://openalex.org/I2960094004","https://openalex.org/I2961216182","https://openalex.org/I3019010403","https://openalex.org/I4210094406","https://openalex.org/I4210107147","https://openalex.org/I4210161852"],"apc_list":null,"apc_paid":null,"fwci":0.5994,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.68216873,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"27","issue":"2","first_page":"133","last_page":"137"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/recurrent-glioblastoma","display_name":"recurrent glioblastoma","score":0.968999981880188},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.9440000057220459},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7630000114440918},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8619999885559082},{"id":"https://openalex.org/keywords/angiogenic-biomarkers","display_name":"angiogenic biomarkers","score":0.9300000071525574},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.9459999799728394},{"id":"https://openalex.org/keywords/thrombospondin-1","display_name":"thrombospondin-1","score":0.9750000238418579},{"id":"https://openalex.org/keywords/microparticles","display_name":"microparticles","score":0.9769999980926514},{"id":"https://openalex.org/keywords/procoagulant-activity","display_name":"procoagulant activity","score":0.9819999933242798},{"id":"https://openalex.org/keywords/lymphopenia","display_name":"lymphopenia","score":0.7440000176429749},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.43299999833106995}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.879339337348938},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.8328825235366821},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7197667360305786},{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.6603304743766785},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6510635018348694},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5126067996025085},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5033690333366394},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.49665218591690063},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4674810767173767},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.46263593435287476},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.45684659481048584},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3705712556838989},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.24009239673614502},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.23702964186668396},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.20120739936828613},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.06751328706741333}],"mesh":[{"descriptor_ui":"D000077146","descriptor_name":"Irinotecan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077204","descriptor_name":"Temozolomide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D003606","descriptor_name":"Dacarbazine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003606","descriptor_name":"Dacarbazine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059250","descriptor_name":"Administration, Metronomic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/cad.0000000000000314","doi":"https://doi.org/10.1097/cad.0000000000000314","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cad.0000000000000314","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},{"id":"pmid:26574999","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26574999","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drugs","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1484121608","https://openalex.org/W1898063915","https://openalex.org/W1918540162","https://openalex.org/W1959628099","https://openalex.org/W1986725172","https://openalex.org/W1993980146","https://openalex.org/W1995301254","https://openalex.org/W2000443501","https://openalex.org/W2019265097","https://openalex.org/W2024930137","https://openalex.org/W2031103433","https://openalex.org/W2033037987","https://openalex.org/W2041906258","https://openalex.org/W2073680052","https://openalex.org/W2096287682","https://openalex.org/W2098771215","https://openalex.org/W2101183874","https://openalex.org/W2105100844","https://openalex.org/W2108285412","https://openalex.org/W2124820060","https://openalex.org/W2131686568","https://openalex.org/W2132697290","https://openalex.org/W2134807618","https://openalex.org/W2147806499","https://openalex.org/W2167709622","https://openalex.org/W2169965478","https://openalex.org/W2170367762","https://openalex.org/W6675346699","https://openalex.org/W6676272449"],"related_works":["https://openalex.org/W2167135893","https://openalex.org/W2169369050","https://openalex.org/W2073680052","https://openalex.org/W2027170726","https://openalex.org/W175351943","https://openalex.org/W2075007956","https://openalex.org/W2127745545","https://openalex.org/W2055159778","https://openalex.org/W2123610802","https://openalex.org/W2536552580"],"abstract_inverted_index":{"This":[0,228],"phase":[1],"II":[2],"study":[3],"was":[4,58,78,117,129,133,142],"conducted":[5],"to":[6,234],"determine":[7],"the":[8,62,143,236],"efficacy":[9],"and":[10,50,72,97,104,187,194,203,216],"safety":[11],"of":[12,66,74,83,154,175,212],"metronomic":[13],"temozolomide":[14],"(TMZ)":[15],"in":[16,20,110,161,222,243],"combination":[17],"with":[18,27,150,225,239],"irinotecan":[19,55],"glioblastoma":[21],"(GB)":[22],"at":[23,29,61],"first":[24,30],"relapse.":[25],"Patients":[26],"GB":[28],"relapse":[31],"received":[32],"TMZ":[33],"50":[34],"mg/m/2day":[35],"divided":[36],"into":[37],"three":[38],"doses,":[39],"except":[40],"for":[41,80,146],"a":[42,81,151],"single":[43],"100":[44,67],"mg/m2":[45,68],"dose,":[46],"administered":[47],"between":[48],"3":[49],"6":[51],"h":[52],"before":[53,112],"every":[54],"infusion.":[56],"Irinotecan":[57],"given":[59,79],"intravenously":[60],"previously":[63],"established":[64],"dose":[65],"on":[69],"days":[70],"8":[71],"22":[73],"28-day":[75],"cycles.":[76],"Treatment":[77],"maximum":[82],"nine":[84,147],"cycles":[85],"or":[86,89,163,172],"until":[87],"progression":[88],"unacceptable":[90],"toxicity":[91],"occurred.":[92],"Vascular":[93],"endothelial":[94],"growth":[95],"factor":[96],"its":[98],"soluble":[99],"receptor":[100],"1,":[101],"thrombospondin-1,":[102],"microparticles,":[103,215],"microparticle-dependent":[105],"procoagulant":[106,218],"activity":[107,219],"were":[108,125,165,220],"measured":[109],"blood":[111],"treatment.":[113],"The":[114],"primary":[115],"objective":[116],"6-month":[118],"progression-free":[119],"survival":[120],"(PFS).":[121],"Twenty-seven":[122],"evaluable":[123],"patients":[124,168,223],"enrolled.":[126],"Six-month":[127],"PFS":[128,132,162],"20.8%.":[130],"Median":[131],"11.6":[134],"weeks":[135,156],"(95%":[136],"confidence":[137],"interval:":[138],"7.5-15.7).":[139],"Stable":[140],"disease":[141],"best":[144],"response":[145,164],"(37.5%)":[148],"patients,":[149],"median":[152],"duration":[153],"11.2":[155],"(4.2-35.85":[157],"weeks).":[158],"No":[159],"differences":[160],"observed":[166],"among":[167],"who":[169],"relapsed":[170],"during":[171],"after":[173],"completion":[174],"adjuvant":[176],"TMZ.":[177],"Grade":[178],"3/4":[179],"adverse":[180],"events":[181],"included":[182],"lymphopenia":[183],"(15%),":[184],"fatigue,":[185],"diarrhea":[186],"febrile":[188],"neutropenia":[189],"(3.7%":[190],"each),":[191],"lymphopenia,":[192],"neutropenia,":[193],"nausea/vomiting":[195],"(11.1%":[196],"each).":[197],"One":[198],"patient":[199,205],"died":[200,206],"from":[201,207],"pneumonia":[202],"one":[204],"pulmonary":[208],"thromboembolism.":[209],"Pretreatment":[210],"levels":[211],"angiogenesis":[213],"biomarkers,":[214],"microparticle-related":[217],"elevated":[221],"compared":[224],"healthy":[226],"volunteers.":[227],"regimen":[229],"is":[230],"feasible,":[231],"but":[232],"failed":[233],"improve":[235],"results":[237],"obtained":[238],"other":[240],"second-line":[241],"therapies":[242],"recurrent":[244],"GB.":[245]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}